DR REDDYS LABORATORIES
|
DR REDDYS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity - Authorised | ₹145 Cr | ₹145 Cr | ₹145 Cr | ₹120 Cr | ₹120 Cr |
| Equity - Issued | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity Paid Up | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
| Share Warrants & Outstandings | ₹145 Cr | ₹131 Cr | ₹146 Cr | ₹143 Cr | ₹127 Cr |
| Total Reserves | ₹33,322 Cr | ₹28,040 Cr | ₹23,057 Cr | ₹18,986 Cr | ₹17,432 Cr |
| Securities Premium | ₹855 Cr | ₹819 Cr | ₹711 Cr | ₹670 Cr | ₹631 Cr |
| Capital Reserves | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
| Profit & Loss Account Balance | ₹30,052 Cr | ₹24,998 Cr | ₹20,023 Cr | ₹16,034 Cr | ₹14,240 Cr |
| General Reserves | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr |
| Other Reserves | ₹350 Cr | ₹159 Cr | ₹259 Cr | ₹218 Cr | ₹498 Cr |
| Reserve excluding Revaluation Reserve | ₹33,322 Cr | ₹28,040 Cr | ₹23,057 Cr | ₹18,986 Cr | ₹17,432 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹33,550 Cr | ₹28,255 Cr | ₹23,286 Cr | ₹19,212 Cr | ₹17,642 Cr |
| Minority Interest | ₹378 Cr | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹406 Cr | ₹219 Cr | ₹128 Cr | ₹195 Cr | ₹250 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹406 Cr | ₹219 Cr | ₹128 Cr | ₹195 Cr | ₹250 Cr |
| Unsecured Loans | ₹380 Cr | ₹380 Cr | - | ₹380 Cr | ₹380 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹380 Cr | ₹380 Cr | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | ₹380 Cr | ₹380 Cr |
| Deferred Tax Assets / Liabilities | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr |
| Deferred Tax Assets | ₹1,778 Cr | ₹1,445 Cr | ₹999 Cr | ₹1,630 Cr | ₹1,343 Cr |
| Deferred Tax Liability | ₹1,349 Cr | ₹471 Cr | ₹370 Cr | ₹354 Cr | ₹303 Cr |
| Other Long Term Liabilities | ₹245 Cr | ₹314 Cr | ₹203 Cr | ₹167 Cr | ₹162 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹51 Cr |
| Total Non-Current Liabilities | ₹633 Cr | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr | ₹-197 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹2,648 Cr | ₹2,614 Cr | ₹2,268 Cr | ₹2,266 Cr | ₹1,811 Cr |
| Sundry Creditors | ₹2,648 Cr | ₹2,614 Cr | ₹2,268 Cr | ₹2,266 Cr | ₹1,811 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹5,503 Cr | ₹4,775 Cr | ₹4,698 Cr | ₹3,661 Cr | ₹3,338 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹156 Cr | ₹106 Cr | ₹117 Cr | ₹134 Cr | ₹98 Cr |
| Interest Accrued But Not Due | - | - | ₹13 Cr | ₹13 Cr | ₹9.40 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | ₹380 Cr | - | - |
| Current maturity - Others | ₹86 Cr | ₹131 Cr | ₹100 Cr | ₹102 Cr | ₹86 Cr |
| Other Liabilities | ₹5,261 Cr | ₹4,538 Cr | ₹4,088 Cr | ₹3,412 Cr | ₹3,144 Cr |
| Short Term Borrowings | ₹3,805 Cr | ₹1,272 Cr | ₹739 Cr | ₹2,708 Cr | ₹2,315 Cr |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹3,805 Cr | ₹1,272 Cr | ₹739 Cr | ₹2,708 Cr | ₹2,315 Cr |
| Short Term Provisions | ₹1,078 Cr | ₹926 Cr | ₹867 Cr | ₹1,131 Cr | ₹640 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹303 Cr | ₹234 Cr | ₹214 Cr | ₹544 Cr | ₹139 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹776 Cr | ₹692 Cr | ₹653 Cr | ₹587 Cr | ₹502 Cr |
| Total Current Liabilities | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr | ₹8,104 Cr |
| Total Liabilities | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
| ASSETS | |||||
| Gross Block | ₹33,146 Cr | ₹24,527 Cr | ₹25,567 Cr | ₹23,096 Cr | ₹21,887 Cr |
| Less: Accumulated Depreciation | ₹14,754 Cr | ₹14,101 Cr | ₹16,348 Cr | ₹14,895 Cr | ₹13,632 Cr |
| Less: Impairment of Assets | ₹165 Cr | ₹0.50 Cr | - | ₹80 Cr | ₹49 Cr |
| Net Block | ₹18,226 Cr | ₹10,426 Cr | ₹9,219 Cr | ₹8,122 Cr | ₹8,206 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹2,399 Cr | ₹1,351 Cr | ₹975 Cr | ₹1,280 Cr | ₹954 Cr |
| Non Current Investments | ₹720 Cr | ₹526 Cr | ₹536 Cr | ₹593 Cr | ₹833 Cr |
| Long Term Investment | ₹720 Cr | ₹526 Cr | ₹536 Cr | ₹593 Cr | ₹833 Cr |
| Quoted | ₹4.90 Cr | ₹25 Cr | ₹28 Cr | ₹120 Cr | ₹453 Cr |
| Unquoted | ₹716 Cr | ₹501 Cr | ₹508 Cr | ₹473 Cr | ₹380 Cr |
| Long Term Loans & Advances | ₹341 Cr | ₹542 Cr | ₹356 Cr | ₹452 Cr | ₹377 Cr |
| Other Non Current Assets | ₹822 Cr | ₹89 Cr | ₹13 Cr | ₹222 Cr | ₹17 Cr |
| Total Non-Current Assets | ₹22,576 Cr | ₹13,001 Cr | ₹11,155 Cr | ₹10,682 Cr | ₹10,998 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹3,331 Cr | ₹4,405 Cr | ₹4,450 Cr | ₹2,023 Cr | ₹1,379 Cr |
| Quoted | ₹8.70 Cr | ₹14 Cr | ₹106 Cr | - | - |
| Unquoted | ₹3,322 Cr | ₹4,391 Cr | ₹4,343 Cr | ₹2,023 Cr | ₹1,379 Cr |
| Inventories | ₹7,109 Cr | ₹6,355 Cr | ₹4,867 Cr | ₹5,088 Cr | ₹4,541 Cr |
| Raw Materials | ₹1,988 Cr | ₹1,861 Cr | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr |
| Work-in Progress | ₹1,653 Cr | ₹1,422 Cr | ₹1,170 Cr | ₹1,289 Cr | ₹1,001 Cr |
| Finished Goods | ₹2,146 Cr | ₹1,987 Cr | ₹1,362 Cr | ₹1,387 Cr | ₹1,373 Cr |
| Packing Materials | ₹600 Cr | ₹505 Cr | - | - | - |
| Stores  and Spare | - | - | ₹393 Cr | ₹380 Cr | ₹329 Cr |
| Other Inventory | ₹722 Cr | ₹581 Cr | ₹757 Cr | ₹676 Cr | ₹624 Cr |
| Sundry Debtors | ₹9,042 Cr | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr |
| Debtors more than Six months | ₹277 Cr | ₹469 Cr | ₹281 Cr | ₹178 Cr | ₹111 Cr |
| Debtors Others | ₹8,913 Cr | ₹7,706 Cr | ₹7,094 Cr | ₹6,618 Cr | ₹4,983 Cr |
| Cash and Bank | ₹2,460 Cr | ₹1,728 Cr | ₹1,730 Cr | ₹2,419 Cr | ₹2,079 Cr |
| Cash in hand | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Balances at Bank | ₹2,460 Cr | ₹1,728 Cr | ₹1,730 Cr | ₹2,419 Cr | ₹2,079 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹1,073 Cr | ₹1,011 Cr | ₹1,204 Cr | ₹737 Cr | ₹850 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹188 Cr | ₹195 Cr | ₹145 Cr | ₹114 Cr | ₹114 Cr |
| Other current_assets | ₹884 Cr | ₹817 Cr | ₹1,058 Cr | ₹623 Cr | ₹736 Cr |
| Short Term Loans and Advances | ₹2,004 Cr | ₹3,276 Cr | ₹927 Cr | ₹844 Cr | ₹723 Cr |
| Advances recoverable in cash or in kind | ₹315 Cr | ₹45 Cr | ₹28 Cr | ₹15 Cr | ₹16 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | ₹65 Cr | ₹17 Cr | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹1,625 Cr | ₹3,215 Cr | ₹899 Cr | ₹830 Cr | ₹707 Cr |
| Total Current Assets | ₹25,018 Cr | ₹24,805 Cr | ₹20,425 Cr | ₹17,788 Cr | ₹14,535 Cr |
| Net Current Assets (Including Current Investments) | ₹11,984 Cr | ₹15,217 Cr | ₹11,853 Cr | ₹8,022 Cr | ₹6,431 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr |
| Contingent Liabilities | ₹109 Cr | ₹109 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr |
| Total Debt | ₹4,677 Cr | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr | ₹3,031 Cr |
| Book Value | - | 1,686.06 | 1,388.98 | 1,145.98 | 1,052.59 |
| Adjusted Book Value | 400.54 | 337.21 | 277.80 | 229.20 | 210.52 |
Compare Balance Sheet of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,594.3 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,708.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| CIPLA | ₹121,525.0 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,147.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| MANKIND PHARMA | ₹93,419.6 Cr | -5% | -8.8% | -14.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.6% |
-3.5% |
-4.3% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses